2454.TW
Investment note tied to the hypothesis that MediaTek (MTK) might ship a TPU/accelerator SerDes at ~300G using PAM6. The call centers on Semtech (SMTC) as the primary levered beneficiary via CTLE-driven link-budget improvements that could materially offset PAM6 SNR penalties. Execution risk is high and the thesis is contingent on several unconfirmed engineering and packaging outcomes.
Recent proof-backed thesis calls
One public recommendation: a buy thesis driven by the potential upside to Semtech (SMTC) if MediaTek succeeds with a PAM6 SerDes for TPUs. Source: https://x.com/insane_analyst (confidence 0.42).
Post argues Semtech (SMTC) is asymmetric upside tied to MediaTek (MTK) successfully delivering a TPU/accelerator SerDes link budget at ~300G using PAM6. Claim: SMTC’s CTLE could provide 4–7 dB SNR gain, helping offset a ~4–5 dB theoretical SNR penalty vs PAM4; with additional design/CPC improvements and strong packaging (EMIB), MTK could “make it.” If MTK succeeds, SMTC upside 2–4x; if MTK fails, still 1.5–2x (implying other demand drivers).
Current stance
Current stance: buy. Rationale: asymmetric upside through SMTC exposure to a possible MTK TPU SerDes win, tempered by significant execution risk and unverified technical details.
- beneficiary via SMTC as the primary levered beneficiary of MTK TPU SerDes feasibility (CTLE-driven link budget improvement) from https://x.com/insane_analyst (confidence 0.42)
Top authors on this asset
Active and historical ticker theses
Active play: SMTC as the primary levered beneficiary of MTK TPU SerDes feasibility; CTLE improvements could provide the needed SNR margin if MTK’s PAM6 approach is viable.
Unlock full asset monitoring
Monitor engineering disclosures from MediaTek and packaging/EMIB developments. Track Semtech technical notes and customer confirmations that would validate CTLE SNR gains and real-world SerDes performance.